Invention Grant
- Patent Title: Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
- Patent Title (中): 哌嗪衍生物，其制备方法及其用于治疗胰岛素抵抗的用途
-
Application No.: US14128416Application Date: 2012-06-22
-
Publication No.: US09150529B2Publication Date: 2015-10-06
- Inventor: Gerard Moinet , Gabriel Baverel , Remi Nazaret , Bernard Ferrier
- Applicant: Gerard Moinet , Gabriel Baverel , Remi Nazaret , Bernard Ferrier
- Applicant Address: FR
- Assignee: METABOLYS
- Current Assignee: METABOLYS
- Current Assignee Address: FR
- Agency: Cantor Colburn LLP
- Priority: FR1155547 20110623
- International Application: PCT/EP2012/062154 WO 20120622
- International Announcement: WO2012/175715 WO 20121227
- Main IPC: C07D241/04
- IPC: C07D241/04 ; C07D295/182 ; C07D295/192 ; C07D295/205 ; C07D295/26 ; A61K31/495 ; A61K31/496 ; A61K31/497 ; C07D295/092 ; C07D213/74 ; C07D241/20 ; C07D277/42 ; C07D295/088 ; C07D295/096 ; C07D295/155 ; C07D307/33 ; C07D495/04 ; A61K31/519 ; A61K45/06
Abstract:
The invention relates to a compound of formula (I), where R1, R2, R7, m, n, and L1 are as defined in claim 1, and to the methods for preparing same, to the pharmaceutical compositions containing same, and to the uses thereof in the treatment of diseases associated with insulin resistance syndrome.
Public/Granted literature
Information query
